Failures halt Phase III trials of Alzheimer's drug
August 07 2012
Phase III studies of bapineuzumab were stopped, creating few ripples in earnings outlooks, but Phase II studies of a subcutaneous ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.